BRPI0821668A2 - Uso - Google Patents

Uso

Info

Publication number: BRPI0821668A2
Authority: BR; Brazil

Application number

BRPI0821668-1A

Other languages

English (en)

Inventor

Jo Klaveness

Gry Stensdrud

Aslak Godal

Jon Erik Braenden

Bjorn Klem

Original Assignee

Photocure Asa

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2007-12-12

Filing date

2008-12-12

Publication date

2015-06-16

2008-12-12 Application filed by Photocure Asa filed Critical Photocure Asa

2015-06-16 Publication of BRPI0821668A2 publication Critical patent/BRPI0821668A2/pt

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/02—Suppositories; Bougies; Bases therefor; Ovules
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A61K31/221—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin with compounds having an amino group, e.g. acetylcholine, acetylcarnitine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
- A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
- A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
- A61K41/0061—5-aminolevulinic acid-based PDT: 5-ALA-PDT involving porphyrins or precursors of protoporphyrins generated in vivo from 5-ALA
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/001—Preparation for luminescence or biological staining
- A61K49/0013—Luminescence
- A61K49/0017—Fluorescence in vivo
- A61K49/0019—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
- A61K49/0021—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules the fluorescent group being a small organic molecule
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0031—Rectum, anus
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
- A61K9/2846—Poly(meth)acrylates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
- A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2886—Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4891—Coated capsules; Multilayered drug free capsule shells
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
- A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Medicinal Chemistry (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Molecular Biology (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Biochemistry (AREA)
Reproductive Health (AREA)
Emergency Medicine (AREA)
Pulmonology (AREA)
Biomedical Technology (AREA)
Biophysics (AREA)
Gynecology & Obstetrics (AREA)
Otolaryngology (AREA)
Urology & Nephrology (AREA)
Virology (AREA)
Endocrinology (AREA)
Biotechnology (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicinal Preparation (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

BRPI0821668-1A 2007-12-12 2008-12-12 Uso BRPI0821668A2 (pt)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GBGB0724279.5A GB0724279D0 (en)	2007-12-12	2007-12-12	Use
PCT/GB2008/004113 WO2009074811A2 (en)	2007-12-12	2008-12-12	Use of 5-aminolevulinic acid and derivatives in a solid form for photodynamic treatment and diagnosis

Publications (1)

Publication Number	Publication Date
BRPI0821668A2 true BRPI0821668A2 (pt)	2015-06-16

Family

ID=39016493

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
BRPI0821668-1A BRPI0821668A2 (pt)	2007-12-12	2008-12-12	Uso

Country Status (12)

Country	Link
US (2)	US20110020441A1 (pt)
EP (2)	EP2231188A2 (pt)
JP (2)	JP5686603B2 (pt)
KR (1)	KR20100095443A (pt)
CN (2)	CN101896203A (pt)
AU (1)	AU2008334426B2 (pt)
BR (1)	BRPI0821668A2 (pt)
CA (1)	CA2708137C (pt)
GB (1)	GB0724279D0 (pt)
NZ (2)	NZ600028A (pt)
RU (2)	RU2521228C2 (pt)
WO (1)	WO2009074811A2 (pt)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB0724279D0 (en) *	2007-12-12	2008-01-23	Photocure Asa	Use
GB0823472D0 (en)	2008-12-23	2009-01-28	Photocure Asa	Product
HUE026911T2 (en)	2009-06-11	2016-07-28	Photocure Asa	Semi-solid preparations and medical products
EP2440188A1 (en) *	2009-06-11	2012-04-18	Photocure ASA	Solid compositions comprising 5-aminolevulinic acid
EP2283830A1 (en) *	2009-07-23	2011-02-16	Actogenix N.V.	Aqueous enteric capsule coating
DE102009028076A1 (de) *	2009-07-29	2011-02-03	Evonik Röhm Gmbh	Beschichtungsmittel zum Tauchbeschichten von Kapselhälften
US9107451B2 (en)	2009-07-29	2015-08-18	Evonik Röhm Gmbh	Coating composition for the dip coating of capsule halves
MX2012010007A (es)	2010-03-01	2012-10-01	Photocure Asa	Composiciones cosmeticas.
US20130211215A1 (en)	2010-06-23	2013-08-15	Photocure Asa	Hyperosmotic preparations comprising 5-aminolevulinic acid or derivative as photosensitizing agent
ES2620780T3 (es)	2010-07-09	2017-06-29	Photocure Asa	Dispositivos que contienen composiciones secas para su uso en terapia fotodinámica
KR101254758B1 (ko) *	2011-02-28	2013-04-15	부산대학교병원	광역동치료의 광증감제로 사용하기 위한 이디티에이를 이용한 아미노레불리닉산 테트라머
RU2454255C1 (ru) *	2011-05-30	2012-06-27	Виктор Александрович Борисов	Способ фотодинамической терапии злокачественных новообразований
WO2013040447A2 (en) *	2011-09-14	2013-03-21	Medicis Pharmaceutical Corporation	Combination therapy with low dosage strength imiquimod and photodynamic therapy to treat actinic keratosis
KR102180174B1 (ko) *	2012-08-03	2020-11-19	포토큐어 에이에스에이	화합물
US20140067024A1 (en)	2012-08-30	2014-03-06	Photocure Asa	Dual panel photodynamic therapy lamp
GB201221123D0 (en)	2012-11-23	2013-01-09	Photocure As	Device for photodynamic treatment
RU2015143129A (ru) *	2013-03-12	2017-04-17	Эпплайд Байорисерч, Инк.	Хелатирующий суппозиторий для улучшенной доставки лекарственных средств
WO2014204001A1 (ja) *	2013-06-21	2014-12-24	国立大学法人岡山大学	異常活性化細胞検出による悪性腫瘍の検査方法および異常活性化細胞除去環流返血治療装置
US20150364550A1 (en) *	2014-06-16	2015-12-17	Infineon Technologies Ag	Optimized layer for semiconductor
CN104306971B (zh) *	2014-10-29	2017-02-15	青岛大学附属医院	一种配合光动力疗法抗宫颈癌的药物组合物
US10603508B2 (en)	2015-10-15	2020-03-31	Dusa Pharmaceuticals, Inc.	Adjustable illuminators and methods for photodynamic therapy and diagnosis
PL3362145T3 (pl)	2015-10-15	2021-07-19	Dusa Pharmaceuticals, Inc.	Regulowany oświetlacz do terapii fotodynamicznej i diagnostyki
CN108697800A (zh) *	2015-12-17	2018-10-23	光治疗Asa公司	用于膀胱癌的光动力疗法（pdt）的方法
GB201522398D0 (en)	2015-12-18	2016-02-03	Photocure As	Device for photodynamic therapy
GB2546128A (en) *	2016-09-28	2017-07-12	Photocure Asa	Pharamaceutical compositions comprising hexaminolevulinic acid and methods of using the same
CN107434753A (zh) *	2017-07-26	2017-12-05	南京大学	5‑氨基乙酰丙酸及其衍生物的泡腾片及其制备方法
CN107854471A (zh) *	2017-10-26	2018-03-30	郭裴哲	一种治疗宫颈糜烂的药物制剂及用途
CN107812190A (zh) *	2017-11-10	2018-03-20	中国医学科学院生物医学工程研究所	一种用于直肠肿瘤治疗的光动力试剂盒及制备方法
US10357567B1 (en) *	2018-01-12	2019-07-23	Dusa Pharmaceuticals, Inc.	Methods for photodynamic therapy
CN108079298B (zh) *	2018-01-26	2021-05-25	南方医科大学南方医院	一种经皮光动力药物5-氨基酮戊酸己酯盐酸盐醇质体及其制备方法和应用
GB201905940D0 (en) *	2019-04-29	2019-06-12	Intract Pharma Ltd	5-aminolevulinic acid for the local treatment of inflammatory bowel disease
KR102265592B1 (ko) *	2020-10-29	2021-06-17	김진왕	5-아미노레불린산 수화염화물을 포함하는 조성물
US20230145771A1 (en) *	2021-11-05	2023-05-11	Dusa Pharmaceuticals, Inc.	Photodynamic therapy illuminator devices and methods
WO2024095232A1 (en) *	2022-11-04	2024-05-10	Dusa Pharmaceuticals, Inc.	Photodynamic therapy methods
CN115671059B (zh) *	2022-11-17	2024-06-11	兆科药业（合肥）有限公司	一种盐酸氨酮戊酸冻干制剂及制备方法

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPS6133111A (ja) *	1984-06-18	1986-02-17	Hisamitsu Pharmaceut Co Inc	直腸投与製剤
US4765978A (en) *	1986-12-16	1988-08-23	Schering Corporation	Novel vaginal suppository
US5079262A (en) *	1989-07-28	1992-01-07	Queen's University At Kingston	Method of detection and treatment of malignant and non-malignant lesions utilizing 5-aminolevulinic acid
US5234940A (en) *	1989-07-28	1993-08-10	Queen's University	Photochemotherapeutic method using 5-aminolevulinic acid and precursors thereof
US5422093A (en) *	1989-07-28	1995-06-06	Queen's University	Photochemotherapeutic method using 5-aminolevulinic acid and precursors thereof
US5955490A (en) *	1989-07-28	1999-09-21	Queen's University At Kingston	Photochemotherapeutic method using 5-aminolevulinic acid and other precursors of endogenous porphyrins
JP3181062B2 (ja) *	1991-01-31	2001-07-03	帝國製薬株式会社	下部消化管崩壊経口製剤
JPH05213752A (ja) *	1992-02-06	1993-08-24	Fujisawa Asutora Kk	坐剤
DE122006000051I1 (de) *	1995-03-10	2007-01-04	Photocure Asa	Ester der 5-Aminolevulins{ure als Mittel zur Photosensibillisierung in der Chemotherapie
US6992107B1 (en) *	1995-03-10	2006-01-31	Photocure Asa	Esters of 5-aminolevulinic acid and their use as photosensitizing compounds in photochemotherapy
GB9504948D0 (en) *	1995-03-10	1995-04-26	Norwegian Radium Hospital Rese	Compounds
US7530461B2 (en) *	1995-03-10	2009-05-12	Photocure Asa	Esters of 5-aminolevulinic acid as photosensitizing agents in photochemotherapy
GB9700396D0 (en) *	1997-01-10	1997-02-26	Photocure As	Photochemotherapeutic compositions
JP4162735B2 (ja) *	1997-02-26	2008-10-08	久光製薬株式会社	セロトニン受容体拮抗薬含有直腸投与製剤
JPH1112197A (ja) *	1997-06-18	1999-01-19	Cosmo Sogo Kenkyusho:Kk	悪性腫瘍診断剤及び治療剤
DE69942205D1 (de) *	1998-08-13	2010-05-12	Cima Labs Inc	Microemulsionen als feste dosisformen zur oralen verabreichung
JP3614305B2 (ja) *	1998-08-28	2005-01-26	株式会社オーバル	流量計の誤計数防止装置
DE10003620A1 (de) *	2000-01-28	2001-08-02	Asat Ag Applied Science & Tech	5-Aminolävulinsäure-Formulierung in nichtwässrigen Lösungsmitteln
DE10034673C1 (de) *	2000-07-17	2002-04-25	Medac Klinische Spezialpraep	Dermales Applikationssystem für Aminolävulinsäure und seine Verwendung
GB0018527D0 (en) *	2000-07-27	2000-09-13	Photocure Asa	Composition
GB0018528D0 (en) *	2000-07-27	2000-09-13	Photocure Asa	Compounds
ATE463237T1 (de) *	2000-08-16	2010-04-15	Gen Hospital Corp	Topische aminolevulinsäure-photodynamische therapie für akne vulgaris
US8101209B2 (en) *	2001-10-09	2012-01-24	Flamel Technologies	Microparticulate oral galenical form for the delayed and controlled release of pharmaceutical active principles
US7264629B2 (en) *	2001-11-09	2007-09-04	Qlt, Inc.	Photodynamic therapy for the treatment of hair loss
US6723750B2 (en) *	2002-03-15	2004-04-20	Allergan, Inc.	Photodynamic therapy for pre-melanomas
US20040171601A1 (en) *	2002-07-31	2004-09-02	Dai Fukumura	Photodynamic and sonodynamic therapy
GB0315671D0 (en) *	2003-07-04	2003-08-13	Chelsea And Westminster Nhs Tr	Improvements in or relating to organic compounds
US20070225518A1 (en) *	2006-03-22	2007-09-27	Zvi Malik	5-Aminolevulinic acid salts and their use
GB0609809D0 (en) *	2006-05-17	2006-06-28	Photocure Asa	Product
GB0724279D0 (en) *	2007-12-12	2008-01-23	Photocure Asa	Use

2007
- 2007-12-12 GB GBGB0724279.5A patent/GB0724279D0/en not_active Ceased
2008
- 2008-12-12 CA CA2708137A patent/CA2708137C/en not_active Expired - Fee Related
- 2008-12-12 BR BRPI0821668-1A patent/BRPI0821668A2/pt not_active IP Right Cessation
- 2008-12-12 JP JP2010537516A patent/JP5686603B2/ja not_active Expired - Fee Related
- 2008-12-12 NZ NZ600028A patent/NZ600028A/xx not_active IP Right Cessation
- 2008-12-12 WO PCT/GB2008/004113 patent/WO2009074811A2/en active Application Filing
- 2008-12-12 KR KR1020107012789A patent/KR20100095443A/ko not_active Application Discontinuation
- 2008-12-12 CN CN200880120455XA patent/CN101896203A/zh active Pending
- 2008-12-12 AU AU2008334426A patent/AU2008334426B2/en not_active Ceased
- 2008-12-12 RU RU2010123086/15A patent/RU2521228C2/ru not_active IP Right Cessation
- 2008-12-12 EP EP08860052A patent/EP2231188A2/en not_active Withdrawn
- 2008-12-12 CN CN201410411870.8A patent/CN104306968A/zh active Pending
- 2008-12-12 US US12/808,177 patent/US20110020441A1/en not_active Abandoned
- 2008-12-12 NZ NZ585977A patent/NZ585977A/en not_active IP Right Cessation
- 2008-12-12 EP EP13186756.6A patent/EP2684573A3/en not_active Withdrawn
2013
- 2013-09-18 JP JP2013192917A patent/JP5863735B2/ja not_active Expired - Fee Related
2014
- 2014-04-02 RU RU2014112548/15A patent/RU2014112548A/ru not_active Application Discontinuation
- 2014-07-17 US US14/333,979 patent/US20150031761A1/en not_active Abandoned

Also Published As

Publication number	Publication date
EP2684573A3 (en)	2014-09-24
RU2014112548A (ru)	2015-10-10
RU2010123086A (ru)	2012-01-20
KR20100095443A (ko)	2010-08-30
CN104306968A (zh)	2015-01-28
JP5686603B2 (ja)	2015-03-18
AU2008334426A1 (en)	2009-06-18
GB0724279D0 (en)	2008-01-23
EP2231188A2 (en)	2010-09-29
JP5863735B2 (ja)	2016-02-17
EP2684573A2 (en)	2014-01-15
JP2014012725A (ja)	2014-01-23
CA2708137A1 (en)	2009-06-18
US20110020441A1 (en)	2011-01-27
WO2009074811A2 (en)	2009-06-18
US20150031761A1 (en)	2015-01-29
NZ585977A (en)	2012-06-29
CA2708137C (en)	2016-11-22
NZ600028A (en)	2013-08-30
JP2011507808A (ja)	2011-03-10
AU2008334426B2 (en)	2014-03-27
RU2521228C2 (ru)	2014-06-27
WO2009074811A3 (en)	2009-08-06
CN101896203A (zh)	2010-11-24

Publication	Publication Date	Title
BRPI0821668A2 (pt)	2015-06-16	Uso
BRPI0821573A2 (pt)	2016-08-09	benzofuropirimidonas
ATE501136T1 (de)	2011-03-15	Imidazopyridinone
ATE514696T1 (de)	2011-07-15	Diphenyl-dihydro-imidazopyridinone
DE112008003636A5 (de)	2010-10-21	Mehrzuggruppierer
DE602008002772D1 (de)	2010-11-11	Polyvinylpyrrolidonpulverzusammensetzungen
DK2132326T3 (da)	2012-12-17	Fremgangsmåder
DE502007001207D1 (de)	2009-09-10	Elektrosaugkopf
BRPI0814519A2 (pt)	2014-09-30	Organopolissiloxano
BRPI0811451A2 (pt)	2014-11-04	Exopolissacarídeo
DE602008000923D1 (de)	2010-05-20	Einzelwaferätzgerät
BRPI0812840A2 (pt)	2014-12-09	2-imidazolinas
DE602008000749D1 (de)	2010-04-15	Buschschneider
BRPI0815547A2 (pt)	2015-02-10	Depsipeptídeos cícliocos
AT505058A3 (de)	2008-12-15	Türschliesssystem
DE602008001234D1 (de)	2010-06-24	Bandmaterialzuführvorrichtung
BRPI0812994A2 (pt)	2014-12-23	Microbiocidas
BRPI1011036A2 (pt)	2017-09-26	uso
DE112008001216A5 (de)	2010-02-04	Magnetronplasmaanlage
DE502008001694D1 (de)	2010-12-16	Mitfahrhubwagen
DE112008003094A5 (de)	2010-08-12	Geomatte
DE602008001674D1 (de)	2010-08-19	Wimpernwickler
DE602008000292D1 (de)	2009-12-31	Werkzeughaltepositioniervorrichtung
DE502008003063D1 (de)	2011-05-19	Magnetventilinjektor
DE112008003196A5 (de)	2011-02-03	Handpipettiergerät

Legal Events

Date	Code	Title	Description
2017-10-10	B07D	Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
2018-04-17	B06F	Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
2019-07-02	B07E	Notice of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]	Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI
2019-09-03	B06U	Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
2019-10-08	B08F	Application fees: application dismissed [chapter 8.6 patent gazette]	Free format text: REFERENTE A 11A ANUIDADE.
2020-01-28	B08K	Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]	Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2544 DE 08-10-2019 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.